The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma
Background - Targeted therapies have improved survival and quality of life for patients with non-small-cell lung cancer with actionable driver mutations. However, epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 gene (HER2, also known as ERBB2) exon 20 insertions...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
3 September 2021
|
| In: |
ESMO open
Year: 2021, Volume: 6, Issue: 5, Pages: 1-12 |
| ISSN: | 2059-7029 |
| DOI: | 10.1016/j.esmoop.2021.100253 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.esmoop.2021.100253 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S2059702921002143 
|
| Author Notes: | M. Kirchner, K. Kluck, R. Brandt, A.-L. Volckmar, R. Penzel, D. Kazdal, V. Endris, O. Neumann, H. Seker-Cin, H. Goldschmid, J. Glade, M. Allgäuer, M. Kriegsmann, H. Winter, T. Muley, S. Perner, N. Frost, M. Reck, S. Fröhling, P. Schirmacher, M. Thomas, J. Budczies, P. Christopoulos & A. Stenzinger |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1787471489 | ||
| 003 | DE-627 | ||
| 005 | 20240415193303.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220128s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.esmoop.2021.100253 |2 doi | |
| 035 | |a (DE-627)1787471489 | ||
| 035 | |a (DE-599)KXP1787471489 | ||
| 035 | |a (OCoLC)1341439607 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kirchner, Martina |d 1973- |e VerfasserIn |0 (DE-588)1017178976 |0 (DE-627)676266363 |0 (DE-576)353239747 |4 aut | |
| 245 | 1 | 4 | |a The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma |c M. Kirchner, K. Kluck, R. Brandt, A.-L. Volckmar, R. Penzel, D. Kazdal, V. Endris, O. Neumann, H. Seker-Cin, H. Goldschmid, J. Glade, M. Allgäuer, M. Kriegsmann, H. Winter, T. Muley, S. Perner, N. Frost, M. Reck, S. Fröhling, P. Schirmacher, M. Thomas, J. Budczies, P. Christopoulos & A. Stenzinger |
| 264 | 1 | |c 3 September 2021 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 28.01.2022 | ||
| 520 | |a Background - Targeted therapies have improved survival and quality of life for patients with non-small-cell lung cancer with actionable driver mutations. However, epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 gene (HER2, also known as ERBB2) exon 20 insertions (Ex20mut) are characterized by a poor response to currently approved tyrosine kinase inhibitors and immunotherapies. The underlying immune biology is not well understood. - Materials and methods - We carried out messenger RNA expression profiling of lung adenocarcinomas (ADCs) with ERBB2 (n = 19) and EGFR exon 20-insertion mutations (n = 13) and compared these to tumors with classical EGFR mutations (n = 40, affecting EGFR exons 18, 19 or 21) and EGFR/ERBB2 mutation-negative lung ADC (EGFR/ERBB2wt, n = 26) focusing on immunologically relevant transcripts. Tumor-infiltrating immune cells were estimated from gene expression profiles. - Results - Cytotoxic cells were significantly lower in EGFR-mutated tumors regardless of the affected exon, while Th1 cells were significantly lower in EGFR-Ex20mut compared to EGFR/ERBB2wt tumors. We assessed the differentially expressed genes of ERBB2-Ex20mut and EGFR-Ex20mut tumors compared to EGFR-Ex18/19/21mut and EGFR/ERBB2wt tumors. Of these, the genes GUSB, HDAC11, IFNGR2, PUM1, RASGRF1 and RBL2 were up-regulated, while a lower expression of CBLC, GBP1, GBP2, GBP4 and MYC was observed in all three comparison groups. The omnibus test revealed 185 significantly (FDR = 5%) differentially expressed genes and we found these four most significant gene expression changes in the study cohort: VHL and JAK1 were overexpressed in ERBB2-Ex20mut and EGFR-Ex20mut tumors compared to both EGFR-Ex18/19/21mut and EGFR/ERBB2wt tumors. RIPK1 and STK11IP showed the highest expression in ERBB2-Ex20mut tumors. - Conclusions - Targeted gene expression profiling is a promising tool to read out the characteristics of the tumor microenvironment from routine diagnostic lung cancer biopsies. Significant immune reactivity and specific immunosuppressive characteristics in ERBB2-Ex20mut and EGFR-Ex20mut lung ADC with at least some degree of immune infiltration support further clinical evaluation of immune-modulators as partners of immune checkpoint inhibitors in such tumors. | ||
| 650 | 4 | |a EGFR exon 20 insertion | |
| 650 | 4 | |a ERBB2 exon 20 insertion | |
| 650 | 4 | |a immunosuppression | |
| 650 | 4 | |a lung adenocarcinoma | |
| 650 | 4 | |a tumor microenvironment | |
| 700 | 1 | |a Kluck, Klaus |e VerfasserIn |0 (DE-588)122679940X |0 (DE-627)1747876127 |4 aut | |
| 700 | 1 | |a Brandt, Regine |e VerfasserIn |0 (DE-588)106314762X |0 (DE-627)81064696X |0 (DE-576)420525084 |4 aut | |
| 700 | 1 | |a Volckmar, Anna-Lena |d 1984- |e VerfasserIn |0 (DE-588)173874916 |0 (DE-627)698776666 |0 (DE-576)134713478 |4 aut | |
| 700 | 1 | |a Penzel, Roland |e VerfasserIn |0 (DE-588)102044021X |0 (DE-627)691221316 |0 (DE-576)360421083 |4 aut | |
| 700 | 1 | |a Kazdal, Daniel |d 1983- |e VerfasserIn |0 (DE-588)114929650X |0 (DE-627)1009614088 |0 (DE-576)496635867 |4 aut | |
| 700 | 1 | |a Endris, Volker |e VerfasserIn |0 (DE-588)1063753686 |0 (DE-627)812590961 |0 (DE-576)422898198 |4 aut | |
| 700 | 1 | |a Neumann, Olaf |e VerfasserIn |0 (DE-588)1033375632 |0 (DE-627)741119498 |0 (DE-576)380962381 |4 aut | |
| 700 | 1 | |a Şeker-Cin, Huriye |e VerfasserIn |0 (DE-588)1083854712 |0 (DE-627)848056949 |0 (DE-576)455756902 |4 aut | |
| 700 | 1 | |a Goldschmid, Hannah |e VerfasserIn |0 (DE-588)1211651568 |0 (DE-627)1700253530 |4 aut | |
| 700 | 1 | |a Glade, Julia |e VerfasserIn |0 (DE-588)122575433X |0 (DE-627)1745638369 |4 aut | |
| 700 | 1 | |a Allgäuer, Michael |e VerfasserIn |0 (DE-588)1178366790 |0 (DE-627)1049312597 |0 (DE-576)517751453 |4 aut | |
| 700 | 1 | |a Kriegsmann, Mark |d 1987- |e VerfasserIn |0 (DE-588)103740324X |0 (DE-627)755668782 |0 (DE-576)39141870X |4 aut | |
| 700 | 1 | |a Winter, Hauke |e VerfasserIn |0 (DE-588)1162076038 |0 (DE-627)1025509773 |0 (DE-576)176791531 |4 aut | |
| 700 | 1 | |a Muley, Thomas |e VerfasserIn |0 (DE-588)1056885432 |0 (DE-627)794179169 |0 (DE-576)16759284X |4 aut | |
| 700 | 1 | |a Perner, Sven Roger |d 1972- |e VerfasserIn |0 (DE-588)124400086 |0 (DE-627)363321047 |0 (DE-576)294154477 |4 aut | |
| 700 | 1 | |a Frost, N. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Reck, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fröhling, Stefan |d 1969- |e VerfasserIn |0 (DE-588)120890046 |0 (DE-627)080950302 |0 (DE-576)188733930 |4 aut | |
| 700 | 1 | |a Schirmacher, Peter |d 1961- |e VerfasserIn |0 (DE-588)1020440112 |0 (DE-627)691221197 |0 (DE-576)360427448 |4 aut | |
| 700 | 1 | |a Thomas, Michael |e VerfasserIn |0 (DE-588)1054438781 |0 (DE-627)79152213X |0 (DE-576)41027089X |4 aut | |
| 700 | 1 | |a Budczies, Jan |d 1970- |e VerfasserIn |0 (DE-588)124086403 |0 (DE-627)706532724 |0 (DE-576)186167679 |4 aut | |
| 700 | 1 | |a Christopoulos, Petros |d 1977- |e VerfasserIn |0 (DE-588)138659702 |0 (DE-627)604886756 |0 (DE-576)308488067 |4 aut | |
| 700 | 1 | |a Stenzinger, Albrecht |e VerfasserIn |0 (DE-588)139606106 |0 (DE-627)703395238 |0 (DE-576)312432755 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t ESMO open |d [London] : Elsevier, 2016 |g 6(2021), 5, Artikel-ID 100253, Seite 1-12 |h Online-Ressource |w (DE-627)84705344X |w (DE-600)2844985-X |w (DE-576)454658516 |x 2059-7029 |7 nnas |a The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma |
| 773 | 1 | 8 | |g volume:6 |g year:2021 |g number:5 |g elocationid:100253 |g pages:1-12 |g extent:12 |a The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.esmoop.2021.100253 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S2059702921002143 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220128 | ||
| 992 | |a 20220128 | ||
| 993 | |a Article | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 994 | |a 2021 | ||
| 998 | |g 139606106 |a Stenzinger, Albrecht |m 139606106:Stenzinger, Albrecht |d 910000 |d 912000 |e 910000PS139606106 |e 912000PS139606106 |k 0/910000/ |k 1/910000/912000/ |p 24 |y j | ||
| 998 | |g 138659702 |a Christopoulos, Petros |m 138659702:Christopoulos, Petros |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PC138659702 |e 950000PC138659702 |e 950900PC138659702 |e 50000PC138659702 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 23 | ||
| 998 | |g 124086403 |a Budczies, Jan |m 124086403:Budczies, Jan |d 910000 |d 912000 |d 50000 |e 910000PB124086403 |e 912000PB124086403 |e 50000PB124086403 |k 0/910000/ |k 1/910000/912000/ |k 0/50000/ |p 22 | ||
| 998 | |g 1054438781 |a Thomas, Michael |m 1054438781:Thomas, Michael |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PT1054438781 |e 950000PT1054438781 |e 950900PT1054438781 |e 50000PT1054438781 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 21 | ||
| 998 | |g 1020440112 |a Schirmacher, Peter |m 1020440112:Schirmacher, Peter |d 910000 |d 912000 |e 910000PS1020440112 |e 912000PS1020440112 |k 0/910000/ |k 1/910000/912000/ |p 20 | ||
| 998 | |g 120890046 |a Fröhling, Stefan |m 120890046:Fröhling, Stefan |d 50000 |e 50000PF120890046 |k 0/50000/ |p 19 | ||
| 998 | |g 1056885432 |a Muley, Thomas |m 1056885432:Muley, Thomas |d 910000 |d 950000 |d 950900 |e 910000PM1056885432 |e 950000PM1056885432 |e 950900PM1056885432 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 15 | ||
| 998 | |g 1162076038 |a Winter, Hauke |m 1162076038:Winter, Hauke |d 50000 |e 50000PW1162076038 |k 0/50000/ |p 14 | ||
| 998 | |g 103740324X |a Kriegsmann, Mark |m 103740324X:Kriegsmann, Mark |d 910000 |d 912000 |d 50000 |e 910000PK103740324X |e 912000PK103740324X |e 50000PK103740324X |k 0/910000/ |k 1/910000/912000/ |k 0/50000/ |p 13 | ||
| 998 | |g 1178366790 |a Allgäuer, Michael |m 1178366790:Allgäuer, Michael |d 910000 |d 912000 |e 910000PA1178366790 |e 912000PA1178366790 |k 0/910000/ |k 1/910000/912000/ |p 12 | ||
| 998 | |g 122575433X |a Glade, Julia |m 122575433X:Glade, Julia |d 910000 |d 912000 |e 910000PG122575433X |e 912000PG122575433X |k 0/910000/ |k 1/910000/912000/ |p 11 | ||
| 998 | |g 1211651568 |a Goldschmid, Hannah |m 1211651568:Goldschmid, Hannah |d 910000 |d 912000 |e 910000PG1211651568 |e 912000PG1211651568 |k 0/910000/ |k 1/910000/912000/ |p 10 | ||
| 998 | |g 1083854712 |a Şeker-Cin, Huriye |m 1083854712:Şeker-Cin, Huriye |p 9 | ||
| 998 | |g 1033375632 |a Neumann, Olaf |m 1033375632:Neumann, Olaf |d 910000 |d 912000 |e 910000PN1033375632 |e 912000PN1033375632 |k 0/910000/ |k 1/910000/912000/ |p 8 | ||
| 998 | |g 1063753686 |a Endris, Volker |m 1063753686:Endris, Volker |d 910000 |d 912000 |e 910000PE1063753686 |e 912000PE1063753686 |k 0/910000/ |k 1/910000/912000/ |p 7 | ||
| 998 | |g 114929650X |a Kazdal, Daniel |m 114929650X:Kazdal, Daniel |d 910000 |d 912000 |e 910000PK114929650X |e 912000PK114929650X |k 0/910000/ |k 1/910000/912000/ |p 6 | ||
| 998 | |g 102044021X |a Penzel, Roland |m 102044021X:Penzel, Roland |d 910000 |d 912000 |e 910000PP102044021X |e 912000PP102044021X |k 0/910000/ |k 1/910000/912000/ |p 5 | ||
| 998 | |g 173874916 |a Volckmar, Anna-Lena |m 173874916:Volckmar, Anna-Lena |d 910000 |d 912000 |e 910000PV173874916 |e 912000PV173874916 |k 0/910000/ |k 1/910000/912000/ |p 4 | ||
| 998 | |g 106314762X |a Brandt, Regine |m 106314762X:Brandt, Regine |d 910000 |d 912000 |e 910000PB106314762X |e 912000PB106314762X |k 0/910000/ |k 1/910000/912000/ |p 3 | ||
| 998 | |g 122679940X |a Kluck, Klaus |m 122679940X:Kluck, Klaus |d 910000 |d 912000 |e 910000PK122679940X |e 912000PK122679940X |k 0/910000/ |k 1/910000/912000/ |p 2 | ||
| 998 | |g 1017178976 |a Kirchner, Martina |m 1017178976:Kirchner, Martina |d 50000 |d 53200 |d 50000 |e 50000PK1017178976 |e 53200PK1017178976 |e 50000PK1017178976 |k 0/50000/ |k 1/50000/53200/ |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1787471489 |e 404712480X | ||
| 999 | |a KXP-PPN1787471489 |e 4047124796 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["M. Kirchner, K. Kluck, R. Brandt, A.-L. Volckmar, R. Penzel, D. Kazdal, V. Endris, O. Neumann, H. Seker-Cin, H. Goldschmid, J. Glade, M. Allgäuer, M. Kriegsmann, H. Winter, T. Muley, S. Perner, N. Frost, M. Reck, S. Fröhling, P. Schirmacher, M. Thomas, J. Budczies, P. Christopoulos & A. Stenzinger"]},"title":[{"title":"The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma","title_sort":"immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma"}],"origin":[{"dateIssuedDisp":"3 September 2021","dateIssuedKey":"2021"}],"id":{"doi":["10.1016/j.esmoop.2021.100253"],"eki":["1787471489"]},"person":[{"given":"Martina","role":"aut","display":"Kirchner, Martina","family":"Kirchner"},{"given":"Klaus","role":"aut","display":"Kluck, Klaus","family":"Kluck"},{"display":"Brandt, Regine","role":"aut","family":"Brandt","given":"Regine"},{"given":"Anna-Lena","family":"Volckmar","display":"Volckmar, Anna-Lena","role":"aut"},{"given":"Roland","family":"Penzel","role":"aut","display":"Penzel, Roland"},{"given":"Daniel","display":"Kazdal, Daniel","role":"aut","family":"Kazdal"},{"given":"Volker","family":"Endris","display":"Endris, Volker","role":"aut"},{"given":"Olaf","role":"aut","display":"Neumann, Olaf","family":"Neumann"},{"display":"Şeker-Cin, Huriye","role":"aut","family":"Şeker-Cin","given":"Huriye"},{"given":"Hannah","display":"Goldschmid, Hannah","role":"aut","family":"Goldschmid"},{"family":"Glade","display":"Glade, Julia","role":"aut","given":"Julia"},{"family":"Allgäuer","display":"Allgäuer, Michael","role":"aut","given":"Michael"},{"given":"Mark","family":"Kriegsmann","role":"aut","display":"Kriegsmann, Mark"},{"given":"Hauke","role":"aut","display":"Winter, Hauke","family":"Winter"},{"display":"Muley, Thomas","role":"aut","family":"Muley","given":"Thomas"},{"given":"Sven Roger","family":"Perner","display":"Perner, Sven Roger","role":"aut"},{"given":"N.","family":"Frost","role":"aut","display":"Frost, N."},{"display":"Reck, M.","role":"aut","family":"Reck","given":"M."},{"role":"aut","display":"Fröhling, Stefan","family":"Fröhling","given":"Stefan"},{"given":"Peter","family":"Schirmacher","display":"Schirmacher, Peter","role":"aut"},{"given":"Michael","display":"Thomas, Michael","role":"aut","family":"Thomas"},{"given":"Jan","display":"Budczies, Jan","role":"aut","family":"Budczies"},{"family":"Christopoulos","display":"Christopoulos, Petros","role":"aut","given":"Petros"},{"role":"aut","display":"Stenzinger, Albrecht","family":"Stenzinger","given":"Albrecht"}],"note":["Gesehen am 28.01.2022"],"language":["eng"],"relHost":[{"corporate":[{"display":"European Society for Medical Oncology","role":"isb"}],"note":["Gesehen am 13.06.24"],"recId":"84705344X","physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"pubHistory":["1.2016 -"],"name":{"displayForm":["European Society for Medical Oncology"]},"title":[{"title_sort":"ESMO open","title":"ESMO open","subtitle":"cancer horizons"}],"disp":"The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinomaESMO open","part":{"volume":"6","extent":"12","issue":"5","pages":"1-12","text":"6(2021), 5, Artikel-ID 100253, Seite 1-12","year":"2021"},"id":{"zdb":["2844985-X"],"eki":["84705344X"],"issn":["2059-7029"]},"origin":[{"publisher":"Elsevier ; BMJ","dateIssuedKey":"2016","publisherPlace":"[London] ; London","dateIssuedDisp":"2016-"}]}],"recId":"1787471489","physDesc":[{"extent":"12 S."}]} | ||
| SRT | |a KIRCHNERMAIMMUNEMICR3202 | ||